Skip to main content

Research Archives

You missed a few: a better way to count health care-associated influenza cases

Dec. 8, 2023—The traditional definition of health care-associated influenza leads to gross undercounting, a Vanderbilt study suggests.

Read more


Pasteurization reduces bioactive component of breast milk

Dec. 6, 2023—Pasteurization of breast milk affects the concentration of osteopontin, a bioactive protein with roles in intestinal, immunological and brain development — suggesting that osteopontin supplementation should be considered when donor milk is provided to preterm infants.

Read more


Role of immunity in kidney injury hints at a potential therapy: study

Dec. 5, 2023—Targeting the cytokine IL-22 could be a new therapeutic approach to prevent kidney injury caused by drugs or toxins, Vanderbilt researchers have discovered.

Read more


Study links gene network and pancreatic beta cell defects to Type 2 diabetes

Dec. 4, 2023—A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes.

Read more


Nonprofits support quest to cure childhood epilepsy

Nov. 29, 2023—Monica Joanna Elnekaveh was doing everything she could to learn what was causing her 18-month-old daughter’s developmental issues. Her relentless quest to find answers eventually led her to Vanderbilt investigative neurologist Jing-Qiong (Katty) Kang, MD, PhD.

Read more


Commensal gut bacterium protects from severe intestinal infection

Nov. 21, 2023— The commensal bacterium Turicibacter sanguinis could be used to protect against severe intestinal infections, Vanderbilt researchers discovered.

Read more


VUMC scientists discover key step to kidney fibrosis

Nov. 21, 2023—Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure.

Read more


Tumor antigens key to improving cancer immunotherapy: study

Nov. 17, 2023—Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients.

Read more


Nasty microbe H. pylori has Achilles’ heel

Nov. 16, 2023—Vanderbilt researchers found that an H. pylori enzyme is essential for colonization of the stomach, suggesting it as a promising therapeutic target for H. pylori infection.

Read more


Twelve at Vanderbilt are among world’s highly cited researchers

Nov. 15, 2023—Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers.

Read more


Novel C. diff structures are required for infection, offer new therapeutic targets

Nov. 15, 2023—Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs.

Read more


Most can lower blood pressure by reducing salt, even those on BP drugs: study

Nov. 13, 2023—New research shows nearly everyone can lower their blood pressure, even people currently on blood pressure- reducing drugs, by lowering their sodium intake.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more